Arrow Greentech Ltd

Arrow Greentech Ltd

₹ 477 -0.19%
22 May - close price
About

Incorporated in 1982, Arrow Greentech
Ltd is in the business of bio-degradable (green) products, high-tech products and having Patents income for such products /technology[1]

Key Points

Business Overview:[1][2]
AGL is India’s largest manufacturer of water-soluble films, specializing in the development, production, and marketing of a diverse range of PVA/PVOH-based films. Its portfolio includes innovative applications such as mouth dissolving strips for pharmaceutical and nutraceutical use. In addition to green packaging solutions, AGL also offers advanced security products and intellectual property services, positioning itself as a multi-vertical technology-driven company.

  • Market Cap 720 Cr.
  • Current Price 477
  • High / Low 818 / 342
  • Stock P/E 17.0
  • Book Value 147
  • Dividend Yield 0.84 %
  • ROCE 28.5 %
  • ROE 20.9 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 76.6% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 30.7%
  • Company's median sales growth is 18.6% of last 10 years

Cons

  • Promoter holding has decreased over last 3 years: -3.77%
  • Working capital days have increased from 155 days to 285 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
47.13 30.59 29.16 24.54 47.68 64.48 57.14 40.30 39.29 32.85 44.80 44.73 34.37
28.69 18.50 18.49 15.76 27.67 35.46 30.73 25.74 26.35 21.01 27.67 28.19 24.37
Operating Profit 18.44 12.09 10.67 8.78 20.01 29.02 26.41 14.56 12.94 11.84 17.13 16.54 10.00
OPM % 39.13% 39.52% 36.59% 35.78% 41.97% 45.01% 46.22% 36.13% 32.93% 36.04% 38.24% 36.98% 29.10%
1.81 1.42 1.16 1.24 2.06 0.68 0.97 1.43 1.73 1.69 1.91 2.07 2.28
Interest 0.36 0.07 0.07 0.06 0.14 0.01 0.03 0.06 0.03 0.04 0.11 0.10 0.06
Depreciation 1.27 0.95 1.20 1.32 1.27 1.09 1.05 1.23 1.36 1.22 1.37 1.32 1.39
Profit before tax 18.62 12.49 10.56 8.64 20.66 28.60 26.30 14.70 13.28 12.27 17.56 17.19 10.83
Tax % 28.68% 30.10% 27.94% 18.17% 23.09% 25.77% 25.74% 26.46% 22.29% 25.10% 23.69% 30.66% 26.32%
13.28 8.73 7.61 7.07 15.89 21.23 19.53 10.81 10.32 9.19 13.40 11.92 7.98
EPS in Rs 8.80 5.79 5.04 4.69 10.53 14.07 12.94 7.16 6.84 6.09 8.88 7.90 5.29
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
20 23 31 39 43 31 27 24 106 132 201 157
11 11 15 27 46 28 23 29 78 80 118 101
Operating Profit 9 12 16 12 -3 4 3 -5 28 52 83 56
OPM % 46% 51% 52% 31% -7% 12% 13% -22% 26% 39% 41% 35%
1 5 2 10 7 2 3 7 4 6 5 8
Interest 0 0 0 0 0 1 1 1 1 0 0 0
Depreciation 1 1 1 4 3 3 4 4 4 5 5 5
Profit before tax 9 16 17 18 1 2 2 -3 27 52 83 58
Tax % 30% 29% 18% 16% 81% 7% -57% -43% 29% 25% 25% 27%
7 11 14 15 0 2 3 -2 19 39 62 42
EPS in Rs 4.65 7.96 9.79 10.74 0.13 1.50 1.79 -1.21 12.51 26.05 41.03 28.16
Dividend Payout % 45% 47% 48% 16% 309% 0% 0% 0% 8% 8% 10% 0%
Compounded Sales Growth
10 Years: 21%
5 Years: 42%
3 Years: 14%
TTM: -22%
Compounded Profit Growth
10 Years: 14%
5 Years: 77%
3 Years: 31%
TTM: -30%
Stock Price CAGR
10 Years: 1%
5 Years: 32%
3 Years: 18%
1 Year: -24%
Return on Equity
10 Years: 23%
5 Years: 27%
3 Years: 31%
Last Year: 21%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 12 12 12 12 12 14 14 14 15 15 15 15
Reserves 10 16 30 38 36 44 46 44 73 111 170 206
0 0 0 0 0 5 4 4 3 0 0 2
9 6 6 6 7 7 7 7 15 10 12 11
Total Liabilities 31 33 47 56 55 70 71 69 106 136 196 234
5 5 16 16 13 17 15 14 12 15 17 18
CWIP 1 1 1 1 1 0 0 1 1 3 2 0
Investments 15 16 19 26 12 11 6 2 1 37 82 113
9 11 11 14 28 42 50 52 92 81 95 103
Total Assets 31 33 47 56 55 70 71 69 106 136 196 234

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
10 7 12 3 -10 10 -0 1 10 20 66 29
-11 3 -12 1 14 -23 -0 0 -18 -16 -58 -27
-2 -7 -2 -6 -2 12 -1 -1 9 -4 -4 -7
Net Cash Flow -3 3 -2 -2 2 -0 -2 0 0 -1 5 -4
Free Cash Flow 6 8 1 1 -11 1 -2 -3 7 9 60 27
CFO/OP 123% 119% 95% 55% 305% 295% 13% -30% 45% 67% 107% 80%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 9 9 21 29 59 31 91 42 72 67 43 72
Inventory Days 72 155 225 200 77 92 136 215 103 155 85 125
Days Payable 171 182 238 101 43 74 71 107 59 19 24 23
Cash Conversion Cycle -90 -19 8 128 93 48 156 150 116 203 103 174
Working Capital Days -102 -35 8 60 83 16 74 63 76 115 65 285
ROCE % 46% 64% 48% 39% 2% 6% 4% -4% 36% 49% 53% 29%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Employee Benefit Expenses
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Total Granted Patents (Cumulative)
Number
Number of Employees
Number
FSSAI Approved Products (Avery Pharma)
Number
Prescription (Rx) Approved Products
Number
Registered Trademarks (India)
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

3 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
68.60% 68.60% 68.60% 68.60% 68.60% 66.75% 64.81% 64.81% 64.81% 64.81% 64.81% 64.83%
0.00% 0.02% 0.00% 1.28% 0.21% 0.09% 0.56% 0.27% 0.25% 0.12% 0.14% 0.06%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.04% 0.11% 0.69% 0.79% 0.82%
31.41% 31.38% 31.42% 30.13% 31.19% 33.16% 34.63% 34.88% 34.84% 34.38% 34.25% 34.28%
No. of Shareholders 8,2018,13712,63013,43014,83822,32022,03822,60521,68521,94721,52121,442

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls